TREA

79294792 - OMASS

Follow

Information

  • Trademark
  • 79294792
  • Serial Number
    79294792
  • Registration Number
    6443577
  • Filing Date
    February 26, 2020
    6 years ago
  • Registration Date
    August 10, 2021
    4 years ago
  • Transaction Date
    October 07, 2023
    2 years ago
  • Status Date
    August 10, 2021
    4 years ago
  • Published for Opposition Date
    May 25, 2021
    5 years ago
  • Location Date
    August 10, 2021
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FITZSIMONS, MICHAEL R
  • Attorney Docket Number
    60895-539468
    Attorney Name
    Rebecca Liebowitz
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
OMASS
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; reagents for medical use, namely reagents for in-vitro laboratory use cells for medical or clinical use, namely cells, cell lines, and cell cultures for use in the production of proteins for therapeutic use; reagents for medical use; biological reagents for medical use; therapeutic antibodies; vaccines
  • GS0421: Scientific and technological services, namely scientific research and development; laboratory research services in the field of chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, analysis and measurement of substances; analysis and measurement of molecules and characteristics; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research; research and development in the fields of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnology research; biotechnology research, namely, biotechnology testing; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; research and development in the pharmaceutical field; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing services; drug discovery services; drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; research and development of molecules for therapeutic purposes; consultancy, advisory and/or information services in relation to all the aforesaid services
Case File Event Statements
  • 10/7/2023 - 2 years ago
    26 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/14/2022 - 4 years ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 1/24/2022 - 4 years ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/24/2022 - 4 years ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/10/2021 - 4 years ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/10/2021 - 4 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/30/2021 - 4 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/25/2021 - 5 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/25/2021 - 5 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/10/2021 - 5 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/5/2021 - 5 years ago
    16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/5/2021 - 5 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/20/2021 - 5 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/15/2021 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/14/2021 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/14/2021 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/29/2021 - 5 years ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/22/2020 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/2/2020 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/2/2020 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/10/2020 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/10/2020 - 5 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/9/2020 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/6/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/6/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/1/2020 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR